SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-18-052229
Filing Date
2018-09-25
Accepted
2018-09-25 20:48:25
Documents
2
Period of Report
2018-09-25

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 7106
2 POA DOCUMENT poa.txt EX-24.3_810775 3920
  Complete submission text file 0001209191-18-052229.txt   14028
Mailing Address CODAN TRUST COMPANY (CAYMAN) LIMITED CRICKET SQ., HUTCHINS DR., GEORGE TOWN GRAND CAYMAN E9 KY1-1111
Business Address CODAN TRUST COMPANY (CAYMAN) LIMITED CRICKET SQ., HUTCHINS DR., GEORGE TOWN GRAND CAYMAN E9 KY1-1111 (345) 949 1040
Pivotal bioVenture Partners Fund I, L.P. (Reporting) CIK: 0001695076 (see all company filings)

State of Incorp.: E9 | Fiscal Year End: 0331
Type: 3 | Act: 34 | File No.: 001-38670 | Film No.: 181086708

Mailing Address 35 GATEHOUSE DRIVE WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE WALTHAM MA 02451 (781) 810-0120
Entasis Therapeutics Holdings Inc. (Issuer) CIK: 0001724344 (see all company filings)

IRS No.: 824592913 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1700 OWENS STREET, SUITE 595 SAN FRANCISCO CA 94158
Business Address 1700 OWENS STREET, SUITE 595 SAN FRANCISCO CA 94158 (415) 697-1002
Pivotal bioVenture Partners Fund I U.G.P., Ltd (Reporting) CIK: 0001752847 (see all company filings)

State of Incorp.: E9 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-38670 | Film No.: 181086709

Mailing Address 1700 OWENS STREET, SUITE 595 SAN FRANCISCO CA 94158
Business Address 1700 OWENS STREET, SUITE 595 SAN FRANCISCO CA 94158 (415) 697-1002
Pivotal bioVenture Partners Fund I G.P., L.P. (Reporting) CIK: 0001752862 (see all company filings)

State of Incorp.: E9 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-38670 | Film No.: 181086710